Works by Goyal, Vinod


Results: 63
    1
    2

    On Solutions of ∆u ≽l P(r)f(u).

    Published in:
    Journal of Inequalities & Applications, 2002, v. 7, n. 4, p. 503, doi. 10.1080/1025583021000018644
    By:
    • GOYAL, SULBHA;
    • GOYAL, VINOD;
    • SCHAEFER, PHILIP W.
    Publication type:
    Article
    3
    4

    Masupirdine (SUVN‐502): Phase‐3 Study for the Potential Treatment of Agitation in Patients with Dementia of the Alzheimer's Type, an Update.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. S6, p. 1, doi. 10.1002/alz.087894
    By:
    • Nirogi, Ramakrishna;
    • Abraham, Renny;
    • Ravula, Jyothsna;
    • Jetta, Satish;
    • Benade, Vijay;
    • Shinde, Anil;
    • Rasheed, Mohammed Abdul;
    • Badange, Rajesh Kumar;
    • Goyal, Vinod Kumar;
    • Palacharla, Veera Raghava Chowdary;
    • Subramanian, Ramkumar;
    • Jayarajan, Pradeep
    Publication type:
    Article
    5

    Masupirdine (SUVN‐502) for the Potential Treatment of Agitation in Patients with Dementia of the Alzheimer's Type: Preliminary Efficacy and Phase‐3 Study Design.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.074068
    By:
    • Nirogi, Ramakrishna;
    • Abraham, Renny;
    • Ravula, Jyothsna;
    • Jetta, Satish;
    • Benade, Vijay;
    • Shinde, Anil K;
    • Rasheed, Mohammed Abdul;
    • Badange, Rajesh Kumar;
    • Goyal, Vinod Kumar;
    • Palacharla, Veera Raghava Chowdary;
    • Subramanian, Ramkumar;
    • Jayarajan, Pradeep
    Publication type:
    Article
    6

    Bioequivalence, food effect and comparative pharmacokinetics of SUVN-1105, a novel granule formulation of abiraterone acetate, to Zytiga in healthy male subjects.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 3, p. 253, doi. 10.1007/s00280-023-04629-1
    By:
    • Nirogi, Ramakrishna;
    • Ravula, Jyothsna;
    • Benade, Vijay;
    • Goyal, Vinod Kumar;
    • Pandey, Santosh Kumar;
    • Dogiparti, Dhanunjay;
    • Jayarajan, Pradeep;
    • Kalaikadhiban, Ilayaraja;
    • Jetta, Satish;
    • Palacharla, Veera Raghava Chowdary
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Ropanicant (SUVN-911), an α4β2 nicotinic acetylcholine receptor antagonist intended for the treatment of depressive disorders: pharmacological, behavioral, and neurochemical characterization.

    Published in:
    Psychopharmacology, 2022, v. 239, n. 7, p. 2215, doi. 10.1007/s00213-022-06108-6
    By:
    • Nirogi, Ramakrishna;
    • Abraham, Renny;
    • Jayarajan, Pradeep;
    • Goura, Venkatesh;
    • Kallepalli, Rajesh;
    • Medapati, Rajesh babu;
    • Tadiparthi, Jayaprakash;
    • Goyal, Vinod kumar;
    • Pandey, Santosh kumar;
    • Subramanian, Ramkumar;
    • Petlu, Surendra;
    • Thentu, Jagadeesh Babu;
    • Palacharla, Veera Raghava Chowdary;
    • Gagginapally, Shankar Reddy;
    • Mohammed, Abdul Rasheed;
    • Jasti, Venkat
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25

    Safety, Tolerability, and Pharmacokinetics of Ropanicant (SUVN-911), a Novel Alpha4 Beta2 Nicotinic Acetylcholine Receptor (α4β2 nAChR) Antagonist, in Healthy Adult and Elderly Subjects.

    Published in:
    Clinical Drug Investigation, 2022, v. 42, n. 9, p. 747, doi. 10.1007/s40261-022-01189-9
    By:
    • Nirogi, Ramakrishna;
    • Benade, Vijay;
    • Goyal, Vinod Kumar;
    • Pandey, Santosh Kumar;
    • Mohammed, Abdul Rasheed;
    • Shinde, Anil;
    • Dogiparti, Dhanunjay;
    • Ravula, Jyothsna;
    • Jetta, Satish;
    • Palacharla, Veera Raghava Chowdary
    Publication type:
    Article
    26
    27

    Safety, Tolerability, and Pharmacokinetics of SUVN-G3031, a Novel Histamine-3 Receptor Inverse Agonist for the Treatment of Narcolepsy, in Healthy Human Subjects Following Single and Multiple Oral Doses.

    Published in:
    Clinical Drug Investigation, 2020, v. 40, n. 7, p. 603, doi. 10.1007/s40261-020-00920-8
    By:
    • Nirogi, Ramakrishna;
    • Mudigonda, Koteshwara;
    • Bhyrapuneni, Gopinadh;
    • Muddana, Nageswara Rao;
    • Shinde, Anil;
    • Goyal, Vinod Kumar;
    • Pandey, Santosh Kumar;
    • Mohammed, Abdul Rasheed;
    • Ravula, Jyothsna;
    • Jetta, Satish;
    • Palacharla, Veera Raghava Chowdary
    Publication type:
    Article
    28
    29
    30

    Omics advances and integrative approaches for the simultaneous improvement of seed oil and protein content in soybean (Glycine max L.).

    Published in:
    2021
    By:
    • Kumar, Virender;
    • Vats, Sanskriti;
    • Kumawat, Surbhi;
    • Bisht, Ashita;
    • Bhatt, Vacha;
    • Shivaraj, S. M.;
    • Padalkar, Gunashri;
    • Goyal, Vinod;
    • Zargar, Sajad;
    • Gupta, Sanjay;
    • Kumawat, Giriraj;
    • Chandra, Subhash;
    • Chalam, V. Celia;
    • Ratnaparkhe, Milind B.;
    • Gill, Balwinder S.;
    • Jean, Martine;
    • Patil, Gunvant B.;
    • Vuong, Tri;
    • Rajcan, Istvan;
    • Deshmukh, Rupesh
    Publication type:
    Literature Review
    31
    32

    Effect of masupirdine (SUVN-502) on cognition in patients with moderate Alzheimer's disease: A randomized, double-blind, phase 2, proof-of-concept study.

    Published in:
    Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2022, v. 8, n. 1, p. 1, doi. 10.1002/trc2.12307
    By:
    • Nirogi, Ramakrishna;
    • Ieni, John;
    • Goyal, Vinod Kumar;
    • Ravula, Jyothsna;
    • Jetta, Satish;
    • Shinde, Anil;
    • Jayarajan, Pradeep;
    • Benade, Vijay;
    • Palacharla, Veera Raghava Chowdary;
    • Dogiparti, Dhanunjay Kumar;
    • Jasti, Venkat;
    • Atri, Alireza;
    • Cummings, Jeffrey
    Publication type:
    Article
    33
    34
    35

    Effects of Masupirdine (SUVN‐502) on Agitation/Aggression and Psychosis in Patients with Probable Alzheimer's Disease: A Post Hoc Analysis.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.062695
    By:
    • Nirogi, Ramakrishna;
    • Jayarajan, Pradeep;
    • Abraham, Renny;
    • Tadiparthi, Jayaprakash;
    • Benade, Vijay;
    • Shinde, Anil K;
    • Rasheed, Mohammed Abdul;
    • Badange, Rajesh Kumar;
    • Goyal, Vinod Kumar;
    • Palacharla, Veera Raghava Chowdary;
    • Ravulu, Jyothsna;
    • Jetta, Satish;
    • Subramanian, Ramkumar
    Publication type:
    Article
    36

    Effect of Concurrent Use of Memantine on The Efficacy of Masupirdine (SUVN‐502): A Post‐hoc Analysis of a Phase‐2 Randomized Placebo‐Controlled Study.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.062688
    By:
    • Goyal, Vinod Kumar;
    • Pandey, Santosh Kumar;
    • Benade, Vijay;
    • Shinde, Anil K;
    • Rasheed, Mohammed Abdul;
    • Badange, Rajesh Kumar;
    • Palacharla, Veera Raghava Chowdary;
    • Ravulu, Jyothsna;
    • Jetta, Satish;
    • Subramanian, Ramkumar;
    • Nirogi, Ramakrishna
    Publication type:
    Article
    37
    38
    39

    SUVN‐I6107: A novel muscarinic M1 receptor‐positive allosteric modulator (M1‐PAM) for the treatment of cognitive deficits: Biomarkers (non‐neuroimaging)/Prognostic utility.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.039288
    By:
    • Abraham, Renny;
    • Goura, Venkatesh;
    • Grandhi, Venkata Ramalingayya;
    • Tadiparthi, Jayaprakash;
    • Ganuga, Narender;
    • Medapati, Rajesh Babu;
    • Muddana, Nageswara Rao;
    • Palacharla, Veera Raghava Chowdary;
    • Bhyrapuneni, Gopinadh;
    • Bojja, Kumar;
    • Mekala, Venkat Reddy;
    • Srirangavaram, Maheswari;
    • Badange, Rajesh Kumar;
    • Reballi, Veena;
    • Goyal, Vinod Kumar;
    • Pandey, Santosh Kumar;
    • Jayarajan, Pradeep;
    • Nirogi, Ramakrishna
    Publication type:
    Article
    40

    Masupirdine in combination with donepezil and memantine in patients with moderate Alzheimer's disease: Subgroup analyses of memantine regimen, plasma concentrations and duration of treatment: Human/Human trials: Other.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.039254
    By:
    • Nirogi, Ramakrishna;
    • Goyal, Vinod Kumar;
    • Bhyrapuneni, Gopinadh;
    • Palacharla, Veera Raghava Chowdary;
    • Ravulu, Jyothsna;
    • Jetta, Satish;
    • Jasti, Venkat
    Publication type:
    Article
    41
    42

    P2‐031: SAFETY, TOLERABILITY AND HUMAN PHARMACOKINETICS OF SUVN‐502, A POTENT AND PURE 5‐HT<sub>6</sub> RECEPTOR ANTAGONIST.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P583, doi. 10.1016/j.jalz.2019.06.1253
    By:
    • Bhyrapuneni, Gopinadh;
    • Goyal, Vinod Kumar;
    • Pandey, Santosh Kumar;
    • Muddana, Nageswara Rao;
    • Chowdary Palacharla, Veera Raghava;
    • Ajjala, Devender Reddy;
    • Mudigonda, Koteshwara;
    • Badange, Rajesh Kumar;
    • Nirogi, Ramakrishna;
    • Jasti, Venkat
    Publication type:
    Article
    43
    44

    P1‐075: IN‐VIVO CHARACTERIZATION OF SUVN‐I2004: AN M<sub>1</sub> POSITIVE ALLOSTERIC MODULATOR (PAM) IN ANIMAL MODELS OF COGNITION AND SAFETY.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P299, doi. 10.1016/j.jalz.2018.06.077
    By:
    • Jayarajan, Pradeep;
    • Abraham, Renny;
    • Vuyyuru, Arun Babu;
    • Yathavakilla, Sumanth;
    • Goura, Venkatesh;
    • Daripelli, Saivishal;
    • Kamuju, Venkatesh;
    • Benade, Vijay;
    • Bhyrapuneni, Gopinadh;
    • Goyal, Vinod Kumar;
    • Pandey, Santosh Kumar;
    • Gagginapalli, Shankar Reddy;
    • Nirogi, Ramakrishna
    Publication type:
    Article
    45

    SUVN-G3031, A SELECTIVE H3 RECEPTOR INVERSE AGONIST: ASSESSMENT OF SAFETY, TOLERABILITY AND PHARMACOKINETICS IN HEALTHY HUMAN VOLUNTEERS.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P261, doi. 10.1016/j.jalz.2017.06.130
    By:
    • Muddana, NageswaraRao;
    • Bhyrapuneni, Gopinadh;
    • Mudigonda, Koteshwara;
    • Jayarajan, Pradeep;
    • Abraham, Renny;
    • Subramanian, Ramkumar;
    • Goyal, Vinod Kumar;
    • Pandey, Santosh Kumar;
    • Boggavarapu, Rajesh Kumar;
    • Ajjala, Devender Reddy;
    • Shinde, Anil K.;
    • Nirogi, Ramakrishna
    Publication type:
    Article
    46

    SUVN-502 + DONEPEZIL + MEMANTINE (TRIPLE COMBINATION) REPRESENTS A PROMISING NEW APPROACH FOR SYMPTOMATIC TREATMENT OF ALZHEIMER’S DISEASE.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P617, doi. 10.1016/j.jalz.2017.06.681
    By:
    • Nirogi, Ramakrishna;
    • Mudigonda, Koteshwara;
    • Ravulu, Jyothsna;
    • Bhyrapuneni, Gopinadh;
    • Benade, Vijay;
    • Muddana, Nageswara Rao;
    • Chowdary Palacharla, Veera Raghava;
    • Ajjala, Devender Reddy;
    • Goyal, Vinod Kumar;
    • Pandey, Santosh Kumar;
    • Abraham, Renny;
    • Jayarajan, Pradeep;
    • Kambhampati, Ramasastry;
    • Shinde, Anil K.
    Publication type:
    Article
    47

    SUVN-D4010: A POTENT AND SELECTIVE 5-HT4 RECEPTOR PARTIAL AGONIST— ASSESSMENT OF SAFETY, TOLERABILITY AND PHARMACOKINETICS IN HEALTHY HUMAN VOLUNTEERS.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P463, doi. 10.1016/j.jalz.2017.06.476
    By:
    • Bhyrapuneni, Gopinadh;
    • Mudigonda, Koteshwara;
    • Chowdary Palacharla, Veera Raghava;
    • Jayarajan, Pradeep;
    • Abraham, Renny;
    • Subramanian, Ramkumar;
    • Goyal, Vinod Kumar;
    • Pandey, Santosh Kumar;
    • Boggavarapu, Rajesh Kumar;
    • Ajjala, Devender Reddy;
    • Rasheed, Mohammed Abdul;
    • Nirogi, Ramakrishna
    Publication type:
    Article
    48

    SUVN-G3031, A POTENT AND SELECTIVE H3 RECEPTOR INVERSE AGONIST: SAFETY, TOLERABILITY AND PHARMACOKINETICS IN HUMANS.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P618, doi. 10.1016/j.jalz.2016.06.1230
    By:
    • Bhyrapuneni, Gopinadh;
    • Mudigonda, Koteshwara;
    • Penta, Kiran Kumar;
    • Chowdary Palacharla, Veera Raghava;
    • Muddana, NageswaraRao;
    • Jayarajan, Pradeep;
    • Abraham, Renny;
    • Subramanian, Ramkumar;
    • Goyal, Vinod Kumar;
    • Pandey, Santosh Kumar;
    • Boggavarapu, Rajesh Kumar;
    • Shinde, Anil K.;
    • Nirogi, Ramakrishna
    Publication type:
    Article
    49

    SUVN-502, POTENT AND PURE 5-HT6 RECEPTOR ANTAGONIST: PROOF-OF-CONCEPT STUDY DESIGN IN MODERATE ALZHEIMER’S DISEASE PATIENTS.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P434, doi. 10.1016/j.jalz.2016.06.833
    By:
    • Nirogi, Ramakrishna;
    • Mudigonda, Koteshwara;
    • Penta, Kiran Kumar;
    • Bhyrapuneni, Gopinadh;
    • Benade, Vijay;
    • Muddana, NageswaraRao;
    • Chowdary Palacharla, Veera Raghava;
    • Ajjala, Devender Reddy;
    • Goyal, Vinod Kumar;
    • Pandey, Santosh Kumar;
    • Abraham, Renny;
    • Jayarajan, Pradeep;
    • Kambhampati, Ramasastry;
    • Shinde, Anil K.
    Publication type:
    Article
    50

    SUVN-D4010, A POTENT AND SELECTIVE 5-HT4 RECEPTOR PARTIAL AGONIST: SAFETY, TOLERABILITY AND PHARMACOKINETICS IN HUMANS.

    Published in:
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P823, doi. 10.1016/j.jalz.2016.06.1673
    By:
    • Jayarajan, Pradeep;
    • Bhyrapuneni, Gopinadh;
    • Mudigonda, Koteshwara;
    • Penta, Kiran Kumar;
    • Muddana, NageswaraRao;
    • Chowdary Palacharla, Veera Raghava;
    • Benade, Vijay;
    • Abraham, Renny;
    • Subramanian, Ramkumar;
    • Goyal, Vinod Kumar;
    • Pandey, Santosh Kumar;
    • Boggavarapu, Rajesh Kumar;
    • Ajjala, Devender Reddy;
    • Rasheed, Mohammed Abdul;
    • Nirogi, Ramakrishna
    Publication type:
    Article